Literature DB >> 12883235

"Lack of clinically significant interference by spironolactone with the Axsym Digoxin II assay" only applies to low-dose therapy with spironolactone.

Werner Steimer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12883235     DOI： 10.1097/00007691-200308000-00013

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  1 in total

1.  A new enzyme-linked chemiluminescent immunosorbent digoxin assay is virtually free from interference of spironolactone, potassium canrenoate, and their common metabolite canrenone.

Authors:  Amitava Dasgupta; Edward Kang; Pradip Datta
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.